| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.49 | 0.002 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |